Deficient expression of the placental anticoagulant annexin A5 (ANXA5) has been associated with thrombophilia-related pregnancy complications and ultimately with recurrent pregnancy loss (RPL). Carrier status of M2/ANXA5 (RPRGL3), common ANXA5 promoter variant, has been identified as genetic cause of reduced ANXA5 levels and proposed as biomarker for successful anticoagulant treatment of RPL women. A murine model of AnxA5 loss of function displayed characteristic placental pathology and fetal loss that was alleviated through anticoagulant intervention. This study identified an alternative means of supplementing anticoagulation, through elevated ANXA5 expression. Physiological micromolar Zn2+ stimulated ANXA5 transcription, raising ANXA5 protein expression and surface abundance on BeWo and human umbilical vein endothelial cells (HUVEC), thus resulting in prolonged coagulation times. Zn2-fed AnxA5 functionally deficient pregnant mice showed a trend to increase litter size when primiparous that grew comparable to wild-type progeny in subsequent pregnancies. Elevated AnxA5 signal upon Zn2+ treatment was confirmed in murine placentae. Micromolar Zn2+ stimulated ANXA5 expression in cell culture directly and alleviated RPL in AnxA5 genetically deficient mice, without notable toxicity effects.
van GenderenHOKenisHHofstraLNarulaJReutelingspergerCP. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta. 2008;1783(6):953–963.
2.
CarcedoMTIglesiasJMBancesPMorganROFernandezMP. Functional analysis of the human annexin A5 gene promoter: a downstream DNA element and an upstream long terminal repeat regulate transcription. Biochem J. 2001;356(pt 2):571–579.
3.
BogdanovaNHorstJChlystunM. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet. 2007;16(5):573–578.
RandJHWuXXAndreeHA. Pregnancy loss in the antiphospholipid-antibody syndrome—a possible thrombogenic mechanism. N Engl J Med. 1997;337(3):154–160.
6.
RandJHWuXXQuinnAS. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol. 2003;163(3):1193–1200.
CarmeilleRDegrelleSAPlawinskiL. Annexin-A5 promotes membrane resealing in human trophoblasts. Biochim Biophys Acta. 2015;1853(9):2033–2044.
9.
DegrelleSAGerbaudPLeconteLFerreiraFPidouxG. Annexin-A5 organized in 2D-network at the plasmalemma eases human trophoblast fusion. Sci Rep. 2017;7:42173.
10.
UekiHMizushinaTLaoharatchatathaninT. Loss of maternal annexin A5 increases the likelihood of placental platelet thrombosis and foetal loss. Sci Rep. 2012;2:827.
11.
ShuFSugimuraMKanayamaNKobayashiHKobayashiTTeraoT. Immunohistochemical study of annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest. 2000;49(1):17–23.
12.
SifakisSSouflaGKoukouraO. Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction. Thromb Res. 2010;125(4):326–331.
13.
GourvasVSoulitzisNKonstantinidouA. Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia. Thromb Res. 2014;133(3):495–500.
14.
MarkoffAGerdesSFeldnerSBogdanovaNGerkeVGrandoneE. Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele. Placenta. 2010;31(10):937–940.
15.
OtaSMiyamuraHNishizawaH. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia. Placenta. 2013;34(12):1202–1210.
16.
RogenhoferNMarkoffAWagnerA. Lessons from the EThIGII trial: proper putative benefit assessment of low-molecular-weight heparin treatment in M2/ANXA5 haplotype carriers. Clin Appl Thromb Hemost. 2017;23(1):27–33.
17.
TüttelmannFIvanovPDietzelC. Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk. Fertil Steril. 2013;100(5):1321–1325.
18.
DemetriouCAbu-AmeroSWhiteS. Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion. Reprod BioMed Online. 2015;31(5):681–688.
19.
AngKCKathirgamanathanSCh’ngES. Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population. J Assist Reprod Genet. 2017;34(4):517–524.
20.
BurtonGJJauniauxEWatsonAL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol. 1999;181(3):718–724.
21.
FishelSBakerDElsonJ. Precision medicine in assisted conception: a multicenter observational treatment cohort study of the annexin A5 M2 haplotype as a biomarker for antithrombotic treatment to improve pregnancy outcome. EBioMedicine2016;10:298–304.
22.
GreerIA. Low-molecular-weight heparin for pregnancy complications. Lancet. 2016;388(10060):2570–2572.
23.
ChenXChuMGiedrocDP. MRE-binding transcription factor-1: weak zinc-binding finger domains 5 and 6 modulate the structure, affinity, and specificity of the metal-response element complex. Biochemistry. 1999;38(39):12915–12925.
24.
WirthMBertholdEGrashoffMPfütznerHSchubertUHauserH. Detection of mycoplasma contaminations by the polymerase chain reaction. Cytotechnology. 1994;16(2):67–77.
25.
BrachvogelBDikschasJMochH. Annexin A5 is not essential for skeletal development. Mol Cell Biol. 2003;23(8):2907–2913.
26.
ZhangBGeorgievOHagmannM. Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by metallothionein. Mol Cell Biol. 2003;23(23):8471–8485.
27.
StittMSWasserloosKJTangXLiuXPittBRSt CroixCM. Nitric oxide-induced nuclear translocation of the metal responsive transcription factor, MTF-1 is mediated by zinc release from metallothionein. Vasc Pharmacol. 2006;44(3):149–155.
28.
ShustermanEBeharierOLevyS. Zinc transport and the inhibition of the L-type calcium channel are two separable functions of ZnT-1. Metallomics. 2017;9(3):228–238.
29.
BischofPMeisserACampanaA. Paracrine and autocrine regulators of trophoblast invasion—A review. Placenta. 2000;21(supplA):S55–S60.
30.
KajiTFujiwaraYYamamotoCSakamotoMKozukaH. Stimulation by zinc of cultured vascular endothelial cell proliferation: possible involvement of endogenous basic fibroblast growth factor. Life Sci. 1994;55(23):1781–1787.
31.
LockwoodCJMurkWKayisliUA. Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab. 2009;94(6):2164–2170.
32.
SchoenbergDRMaquatLE. Regulation of cytoplasmic mRNA decay. Nat Rev Genet. 2012;13(4):246–259.
33.
GüntherVLindertUSchaffnerW. The taste of heavy metals: gene regulation by MTF-1. Biochim Biophys Acta. 2012;1823(9):1416–1425.
34.
NishimotoFSakataMMinekawaR. Metal transcription factor-1 is involved in hypoxia-dependent regulation of placenta growth factor in trophoblast-derived cells. Endocrinology. 2009;150(4):1801–1808.
35.
SchleussnerEKaminGSeligerG. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med. 2015;162(9):601–609.
36.
WilsonRLBianco-MiottoTLeemaqzSYGrzeskowiakLEDekkerGARobertsCT. Early pregnancy maternal trace mineral status and the association with adverse pregnancy outcome in a cohort of Australian women. J Trace Elem Med Biol. 2018;46:103–109.
37.
AngKCKathirgamanathanSCh’ngES. Elevated annexin A5 plasma levels in term pregnancies of M2/ANXA5 carriers. Thromb Res. 2017;156:87–90.
38.
AçikgozSHarmaMHarmaMMunganGCanMDemirtasS. Comparison of angiotensin-converting enzyme, malonaldehyde, zinc, and copper levels in preeclampsia. Biol Trace Elem Res. 2016;113(1):1–8.
39.
TianXAnthonyKNeubergerTDiazFJ. Preconception zinc deficiency disrupts postimplantation fetal and placental development in mice. Biol Reprod. 2014;90(4):83.
40.
SilvaJFSerakidesR. Intrauterine trophoblast migration: a comparative view of humans and rodents. Cell Adh Migrat. 2016;10(1-2):88–110.
